As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 3, 2012
by Alan Mozes for MSN Health:
In surprise finding, women who had higher levels of adiponectin were more likely to develop dementia
Rising levels of a hormone associated with sensitizing the body to insulin appears to raise the risk for developing dementia and Alzheimer’s among women, new research reveals. The hormone in question, adiponectin, is derived from visceral fat. It is known to play a role in regulating the metabolism of glucose and lipids, while also carrying certain anti-inflammatory characteristics.
So, the finding is therefore somewhat unexpected, given that insulin resistance and inflammation are considered to be hallmarks of both type 2 diabetes and Alzheimer’s disease (AD). The logical presumption would have been that anything that lowers insulin resistance and inflammation might also reduce the risk for dementia.
Study leader Thomas van Himbergen, of the Lipid Metabolism Laboratory with the Human Nutrition Research Center on Aging at Tufts University in Boston, and his colleagues report their finding online Jan. 2 in the Archives of Neurology.
“It is well established that insulin signaling is dysfunctional in the brains of patients with AD, and since adiponectin enhances insulin sensitivity, one would also expect beneficial actions protecting against cognitive decline,” van Himbergen said in a journal news release. “Our data, however, indicate that elevated adiponectin level was associated with an increased risk of dementia and AD in women.”
The authors note that the global incidence of dementia is projected to double over the next two decades, at which point it will affect roughly 72 million people.
To get at possible mechanism and indicators of the onset of Alzheimer’s, the team took blood samples from 541 women over the course of 13 years. The samples were measured for levels of a number of markers, including glucose, insulin and adiponectin. All patients were simultaneously monitored for dementia symptoms.
During the study, 159 patients went on to develop dementia, of which 125 were Alzheimer’s cases.
In the end, the investigators concluded that only a rise in adiponectin signaled an increased risk for both all-cause dementia and/or Alzheimer’s.
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
Foods can determine whether someone will suffer from dementia in later years, according to researchers at the Hebrew University of Jerusalem’s Faculty of Agriculture, Food and Environment in Rehovot. A large-scale international study that...
Taking care of someone with Alzheimer’s disease and other forms of dementia is not an easy task. Caregiving is a long-term endeavour that is mentally, emotionally, physically, and financially demanding, and is a role that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.